EcoDrugPlus

Ensembl ID : ENSEBUG00000009122
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSEBUG00000009151
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSEBUG00000012649
Gene Symbol: -
Cross references: -
260 Possible Orthologues:

Ensembl ID : ENSEBUG00000012724
Gene Symbol: -
Cross references: -
362 Possible Orthologues:

Ensembl ID : ENSEBUG00000012785
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSEBUG00000012880
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSEBUG00000012914
Gene Symbol: -
Cross references: -
260 Possible Orthologues:

Ensembl ID : ENSEBUG00000012934
Gene Symbol: -
Cross references: -
265 Possible Orthologues:

Ensembl ID : ENSEBUG00000012944
Gene Symbol: -
Cross references: -
321 Possible Orthologues:

Ensembl ID : ENSEBUG00000012983
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSEBUG00000013021
Gene Symbol: -
Cross references: -
260 Possible Orthologues:

Ensembl ID : ENSEBUG00000013114
Gene Symbol: -
Cross references: -
362 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).